Patents by Inventor Chengwei Shi

Chengwei Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12117545
    Abstract: The disclosure provides a method for estimating a direction of arrival of an L-type coprime array based on coupled tensor decomposition. The method includes: constructing an L-type coprime array with separated sub-arrays and modeling a received signal; deriving a fourth-order covariance tensor of the received signal of the L-type coprime array; deriving a fourth-order virtual domain signal corresponding to an augmented virtual uniform cross array; dividing the virtual uniform cross array by translation; constructing a coupled virtual domain tensor by stacking a translation virtual domain signal; and obtaining a direction of arrival estimation result by coupled virtual domain tensor decomposition.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: October 15, 2024
    Assignee: Zhejiang University
    Inventors: Hang Zheng, Chengwei Zhou, Zhiguo Shi, Jiming Chen
  • Publication number: 20240295595
    Abstract: Disclosed in the present invention is a space spectrum estimation method of a super-resolution coprime planar array based on tensor filling of an optimal structured virtual domain, which mainly solves problems that pieces of missing elements in the virtual domain tensor of the existing method are difficult to be filled effectively.
    Type: Application
    Filed: February 16, 2022
    Publication date: September 5, 2024
    Applicant: Zhejiang University
    Inventors: Zhiguo SHI, Hang ZHENG, Jiming CHEN, Chengwei ZHOU, Yong WANG
  • Publication number: 20240265846
    Abstract: Provided are a method for driving a light-emitting substrate, a driving circuit and a display apparatus. The light-emitting substrate includes: at least one control region, which includes a plurality of light-emitting sub-regions, the light-emitting sub-region includes a plurality of light-emitting elements which are connected in series and/or in parallel; each light-emitting sub-regions includes a first signal end and a second signal end, in a same control region, the first signal ends of all the light-emitting sub-regions are electrically connected with each other, and the second signal ends of the different light-emitting sub-regions are independent of each other; the method includes: loading a first signal to the first signal ends in the control region; and loading second signals to the second signal ends of each of the plurality of the light-emitting sub-regions in the control region when a first duration is delayed after the first signal is provided.
    Type: Application
    Filed: April 26, 2022
    Publication date: August 8, 2024
    Inventors: Renhui YU, Xiaoyang LIU, Hongzhou XIE, Xin CHEN, Meizhen CHEN, Yi ZHENG, Zhiliang ZHENG, Ying TIAN, Chengwei SHI, Shulian LIN, Qingna HOU, Kai DIAO, Liangliang REN
  • Publication number: 20220133694
    Abstract: The present invention relates to novel methods and pharmaceutical compositions for the treatment of heart failure in a patient.
    Type: Application
    Filed: July 9, 2021
    Publication date: May 5, 2022
    Inventors: Adel Remond RIZKALA, Victor Chengwei SHI, Fabian CHEN
  • Patent number: 11058667
    Abstract: The present invention relates to sacubitril-valsartan dosage regimens for the treatment of heart failure in a patient.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: July 13, 2021
    Assignee: Novartis AG
    Inventors: Adel Remond Rizkala, Victor Chengwei Shi, Fabian Chen
  • Publication number: 20210077461
    Abstract: The present invention relates to methods and pharmaceutical compositions for the prevention or in delaying time to first occurrence of mortality, in particular cardiovascular death, and/or of cardiovascular hospitalizations in a patient suffering from chronic systolic heart failure, comprising administration of a therapeutically effective amount, or a prophylactically effective amount, of an Angiotensin Receptor Neprilysin inhibitor (ARNi) or of a combination of an Angiotensin Receptor Blocker (ARB) with a Neutral Endopeptidase inhibitor (NEPi) or with a NEPi pro-drug to said patient.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Inventors: Victor Chengwei SHI, Martin LEFKOWITZ, Adel Remond RIZKALA
  • Publication number: 20180125820
    Abstract: The present invention relates to sacubitril-valsartan dosage regimens for the treatment of heart failure in a patient.
    Type: Application
    Filed: May 9, 2016
    Publication date: May 10, 2018
    Inventors: Adel Remond Rizkala, Victor Chengwei SHI, Fabian CHEN
  • Publication number: 20160213646
    Abstract: The present invention relates to methods and pharmaceutical compositions for the prevention or in delaying time to first occurrence of mortality, in particular cardiovascular death, and/or of cardiovascular hospitalizations in a patient suffering from chronic systolic heart failure, comprising administration of a therapeutically effective amount, or a prophylactically effective amount, of an Angiotensin Receptor Neprilysin inhibitor (ARNi) or of a combination of an Angiotensin Receptor Blocker (ARB) with a Neutral Endopeptidase inhibitor (NEPi) or with a NEPi pro-drug to said patient.
    Type: Application
    Filed: August 26, 2014
    Publication date: July 28, 2016
    Applicant: NOVARTIS AG
    Inventors: Victor Chengwei SHI, Martin LEFKOWITZ, Adel Remond RIZKALA
  • Publication number: 20160206597
    Abstract: The present invention relates to methods and pharmaceutical compositions for renal protection in a mammal in need thereof, such as a mammal having a disease manifested by atrial enlargement and/or remodeling or suffering from hypertension or heart failure or being prone to suffering from hypertension and/or heart failure, comprising administration of a therapeutically effective amount, or a prophylactically effective amount, of an Angiotensin Receptor Neprilysin inhibitor (ARNi) or of a combination of an Angiotensin Receptor Blocker (ARB) with a Neutral Endopeptidase inhibitor (NEPi) or with a NEPi pro-drug to said mammal.
    Type: Application
    Filed: August 26, 2013
    Publication date: July 21, 2016
    Inventors: Toni Lynne Bransford, Bryan BURKEY, Thomas LANGENICKEL, Martin LEFKOWITZ, Victor Chengwei SHI
  • Publication number: 20040025198
    Abstract: Thy-marrow composite tissue construct and composite organ for creating hematopoietic chimerism and inducing long-term stable immunological tolerance in a transplant recipient, especially a human xenotransplant recipient of a non-human mammalian (e.g., pig) organ.
    Type: Application
    Filed: June 11, 2003
    Publication date: February 5, 2004
    Inventors: Philip Lake, Victor Chengwei Shi
  • Publication number: 20020152490
    Abstract: Thy-marrow composite tissue construct and composite organ for creating hematopoietic chimerism and inducing long-term stable immunological tolerance in a transplant recipient, especially a human xenotransplant recipient of a non-human mammalian (e.g., pig) organ.
    Type: Application
    Filed: April 12, 2001
    Publication date: October 17, 2002
    Inventors: Philip Lake, Victor Chengwei Shi
  • Patent number: 6365619
    Abstract: A method is disclosed of treating transplant-associated arteriosclerosis in a mammal which comprises administering to a mammal, preferably man, in need of such treatment an effective amount of a VLA-4 antagonist of formula I and a VCAM-1 inhibitor of formula II.
    Type: Grant
    Filed: July 22, 1999
    Date of Patent: April 2, 2002
    Assignee: Novartis AG
    Inventor: Victor Chengwei Shi
  • Patent number: 6248933
    Abstract: A mouse model for vein graft stenosis useful for identifying compounds which reduce or prevent such stenosis, consisting of a mouse engrafted with an autogenous vein which exhibits detectable stenosis within 30 days of transplantation. Also disclosed are therapeutic methods for inhibiting the development of vein graft stenosis.
    Type: Grant
    Filed: November 6, 1998
    Date of Patent: June 19, 2001
    Assignee: President and Fellows of Harvard College
    Inventors: Edgar Haber, Chengwei Shi, Nicholas E. S. Sibinga
  • Patent number: 5675062
    Abstract: A mouse model for transplant arteriosclerosis useful for identifying compounds which reduce or prevent such arteriosclerosis, consisting of a mouse engrafted with a histoincompatible artery which exhibits detectable arteriosclerosis within 30 days of transplantation. Also disclosed are therapeutic methods for inhibiting the development of transplant arteriosclerosis in mammalian recipients of allografted organs.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: October 7, 1997
    Assignee: President and Fellows of Harvard College
    Inventors: Edgar Haber, Chengwei Shi, Wen-Sen Lee